Terminated PHASE2 INTERVENTIONAL 1-arm NCT01426620

Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer (BIT-2)

Salvage Therapy With Docetaxel and Blueberry Powder in Non-Small Cell Lung Cancer

Sponsor: James Graham Brown Cancer Center

Updated 6 times since 2017 Last updated: Mar 1, 2018 Started: Jun 30, 2011 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow accrual

Other terminated trials from James Graham Brown Cancer Center

See all terminations from James Graham Brown Cancer Center

Other Non-small Cell Lung Cancer trials with similar outcome

Browse all Non-small Cell Lung Cancer trials

This PHASE2 trial investigates Non-small Cell Lung Cancer and is currently terminated or withdrawn. James Graham Brown Cancer Center leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Mar 2018 — Jun 2018 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Mar 2018 [monthly]

Terminated PHASE2

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

James Graham Brown Cancer Center
University of Louisville

Data source: University of Louisville

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Louisville, United States